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Summary
High levels of unintegrated viralDNA accumulate during human immunodeficiency virus type
1 (HIV1) infection of CEM T cells. Reinfection of already infected cells is required to attain
these levels and reinfection also promotes the development of HIV-induced cytopathology. Rates
of virus production, however, are independent of the accumulation of unintegrated viralDNA .
Neutralizing antibody added soon after infection reduced viralDNA levels without appreciably
affecting the production of cell-free viral p24 antigen or reverse transcriptase activity. Only 50
pMAZT were required to reduce the accumulation ofunintegrated viralDNA by50% in contrast
to the 25 nM required to inhibit virus production by 50%. Cytopathology,-as measured by number
of syncytia in infected cell cultures, was correlated with highly elevated levels of unintegrated
viralDNA . The minimal levels ofunintegrated viral DNA present constitutively in the persistently
infected HCEM cell line were consonant with the absence of cytopathic effects in these cells .
These data demonstrate that inhibiting the reinfection ofalreadyinfected cells modulates cytopathic
HIV-1 infection to a form that is persistent and noncytopathic .
Depletion ofCD4T lymphocytes is an important feature
of the natural history of HIV-1 infection (1, 2) . Re-
duced numbers in this cell population predict disease progres-
sion (1-3) and are likely to contribute to immunodeficiency
(4) . HIV-1 infection in vitro is rytopathic forT lymphocytes
(5-7) and T lymphoid cell lines (8, 9) . This cytopathology
occurs by the formation of syncytiawhen infected and unin-
fected CD4+ cells are admixed (8, 9) and direct cell killing
by a mechanism independent of cell fusion (10) . Based on
the cytopathic effects of HIV-1 infection ofT cells in vitro,
this mechanism was proposed to be a crucial feature of viral
pathogenesis in AIDS (6, 5, 11, 12) . In this study, we have
examined the role of reinfection and viralDNA accumula-
tion in cytopathic and persistent HIV-1 infection of the CEM
cell line .
Host-pathogen interactions leading to cytopathology have
been characterized extensively in avian retrovirus models.
The accumulation of high levels ofunintegrated viralDNA
is a recognized feature of rytopathic infection by these retro-
viruses (13, 14) and was also shown to be an important marker
of pathogenesis in the case of feline leukemia virus infec-
tion of cats (15) and equine infectious anemia virus infection
of horses (16) .
Unintegrated viralDNA is generated by reverse transcrip-
tion of infecting viralRNA . A linear viralDNA molecule
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flanked at both ends by long terminal repeat (LTR)t se-
quences (17) is generally found to be the most abundant form
of unintegrated viral DNA . Intramolecular recombination
between the LTR sequences then generates a circular mole-
cule with one LTR that is of intermediate abundance . A cir-
cular DNA form with two LTR seems to arise via direct
ligation ofthe ends of a linear molecule and is the least abun-
dant species . Importantly, these DNA species are products
of the reverse transcriptase reaction pathway and have no in-
trinsic capacity for replication (for a review see reference 18) .
The correlation between accumulation of viralDNA and
cytopathology helped to confirm that the cytopathic avian
retroviruses infect, replicate, and reinfect target cells more
rapidly than these cells can establish interference immunity
(14) . The small fraction of cells that survive the initial infec-
tion maintain reduced levels of unintegrated DNA and pro-
duce virus constitutively without evident cytopathic effects
(13) . These characteristics of the dynamic interaction of on-
cornaviruses with their host cells provided a model for inves-
tigating mechanisms of the rytopathic HIV-1 infection ofT
cells. Our studies confirm that reinfection of already infected
cells promotes HIV-induced cytopathology. These results may
1 Abbreviations used in this paper . LTR, long terminal repeat ; moi, mul-
tiplicity of infection ; TCID, tissue culture infectious dose.
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cytopathic effects ofHIV -1 in infected individuals and for de-
termining the contribution of this mechanism toTlympho-
cyte depletion .
Materials and Methods
Cell Lines and Virus Strains.
￿
CEM cells were maintained at den-
sities between 105 and 10 6 cells/ml in RPMI 1640 medium with
10% heat-inactivated FCS supplemented with penicillin/strep-
tomycin/glutamine . The cells were passaged on the day before in-
fection . TheHCEM cell line (19) is persistently infected with the
LAVlb strain of HIV-1 (20) andproduces constitutively 5 x 10,
tissue culture infectious doses per ml of HIV-1, as assayedby ter-
minal dilution inMT-2 cells (21) or in CEM cells. Cell-free super-
natants of HCEM were used as inocula in all experiments .
Infection and Drug Tissues .
￿
To achieve a multiplicity of infec-
tion (moi) of 1 tissue culture infectious dose (TCID)/cell, CEM
cells at 5 x 105/ml were admixed with an equal volume of cell-
free HCEM supernatant containing 5 x 105 TCID5o/ml . Two
volumes of medium were added to this mixture, andthe cells were
incubated for 3-5 d .
Cells were pretreated with 3'-azido-3'-deoxythymidine (AZT,
zidovudine ; Aldrich ChemicalCo ., Inc., Milwaukee, WI) for 1 h
before infection . For experiments with neutralizing antibody, as-
cites fluid containing the 110.4 murine mAb (22 ; provided by
Genetic Systems, Inc., Seattle, Washington) was added directly to
culture medium ; the volume of ascites fluid represented 10-^ of
the total culture volume. A dilution of 10-6 inhibited plaque for-
mation (23) by 50%, and a dilution of 10 -° inhibited plaque for-
mation and infectivity ofCEM cells by >95% (not shown) . This
mAbdoes notblock the interaction ofCD4 with the gp120 enve-
lope glycoprotein of HIV-1 (24) .
Analysis ofVirus and ViralDNAAccumulation .
￿
The reverse tran-
scriptase activity ofcell-free supernatants indicated the rates ofvirus
production in infected cell cultures (5) . Viralp24 antigen wasquan-
titated by ELISA (Abbott Laboratories,N. Chicago, IL) . ViralDNA
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was prepared by the method of Hirt (25) and analyzed by restric-
tion enzyme digestion andDNAblotting (19) . All of the hybrid-
ization experiments were probed with radiolabeledARV-2cDNA
(26) that contained the entire viral sequence. Size markers were
included in each gel to confirm the assignments made for individual
DNA species .
Results
Kinetics of Unintegrated Viral DNA Accumulation in T
Cells. The presence of unintegrated, circularDNA mole-
cules containing one or two LTR sequences and an unin-
tegrated linearDNA form with twoLTR had been demon-
strated previously in CEM cells acutely or persistently infected
by HIV-1 . The identity of each form was confirmed by re-
striction mapping and blot hybridization (19) . The LAV1
genome contains a single BamHI restriction endonuclease site
at position 8068 (27) ; thus, BamHI digestion of HirtDNA
provides a convenient method for displaying the three dis-
crete forms of viralDNA. Subsequent to BamHI digestion,
the circular DNA containing two LTR is present as a 9.8
kilobase pair (kb) fragment . The circularDNA containing
1 LTR migrates as a 9.1 kb band . The linearDNA releases
two fragments upon BamHI digestion ; the higher molec-
ular weight fragment is 8.6 kb and the smaller fragment
representing the 3' end of the viral genome is present as a
1.25 kb piece.
Cultures infected with 1 TCID/cell ofHIV-1 were exam-
ined daily for the presence of unintegrated viral DNA (Fig.
1) . Maximum viralDNAlevels were attained within4dafter
infection . Fig . 1 is a short exposure of this blot hybridization
in ordernot to darken completely the lanes representing days
3 and 4 after infection . The appearance of unintegrated viral
DNA on day 1 was clearly visible in longer exposures (not
shown) and is apparent in Fig . 5 . The decrease in hybridiza-
Unintegrated Human Immunodeficiency Virus 1 DNA in T Cells
Figure 1 . Accumulation of viral
DNA during acute infection ofCEM
cells by HIV1. Cells were infected at
a multiplicity of 1 TCIDso per cell .
Samples were removed at daily intervals,
and unintegrated viral DNA was
purified by Hirt extraction (25) . The
DNA samples were digested with
BamHI restriction endonuclease (27) .
The products of BamHI digestion are
indicated at the left ; the 1.25 kb frag-
ment is one end of the linear molecule
releasedby BamHI cleavage . The panel
on the left shows the kinetics of viral
DNA accumulation throughout 5 d of
infection . Theinset is an enlarged view
of the samples 3 and4d after infection
to emphasize the relative increases in
1 LTR circles .Figure 2.
￿
Neutralizing antibody prevents accumulation of viral DNA
during acute infection . Neutralizing mAb 110.4 (24) was addedat various
intervalsbefore and after infectionand cells were cultured in medium con-
taining the antibody. 3d after infection, samples were collectedandDNA!
was extracted, digested, and analyzed by blot hybridization as for Fig.
1. The values at the top ofthe figure indicate the times of antibody addi-
tion in hours after infection. The value of -1 indicates treatment with
neutralizing antibody 1 h before virus infection. The designation NA
represents the degree of viral DNAaccumulation in the absence of neu-
tralizing antibody.
tion intensity at day 5 after infection is due mainly to the
loss of viable cells in the culture.
Effects ofNeutralizing Antibody on ViralDNA Accumula-
tion and Cytopathology.
￿
In previous studies ofcytopathic avian
Table 1 .
￿
Virus and Viral Antigen Production in Cells Treated with Neutralizing mAb
Antibody addition
(h, after infection)
￿
NA'
￿
-1"
Reverse transcriptaset
￿
19 ± 3
￿
0.9 ± 0.3
p24 Antigens
￿
102
￿
<1
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retroviruses, neutralizing antibody added after infection
blocked reinfection ofalready infected cells andprevented viral
DNA accumulation and cytopathology (13, 14). To explore
the hypothesis that reinfection is essential for viralDNA ac-
cumulation andcytopathology in T cell cultures, neutralizing
mAbwasadded at various intervals before and after infection
of CEM cells with HIV1 . We then examined viral DNA
accumulation, virus production, and the extent of cytopathic
effects in these cultures . ThemAb 110.4 was used in these
experiments . This antibody recognizes an epitope locatedbe-
tween amino acids 303 and 323 of the viral envelope protein
and inhibits virus infectionwithout blocking binding of gp120
to theCD4 receptor (24) . The 110.4 mAb is type-specific
in that it neutralizes only theLAV1b~, strain of HIV-1 (22) .
The levels of unintegrated viralDNA were examined by
blot hybridization at various intervals after adding antibody
to infected cell cultures (Fig. 2) . The input moi used in these
experiments (1 TCID/cell) yielded at least 30% of the cells
as virus antigen-positive within 24 h (not shown) . Addition
ofmAb 110.4 before infection eliminated all detectable viral
DNA accumulation, therebyconfirming the neutralizing ac-
tivity of this antibody. Antibody added within 48 h after
infection reduced significantly the viralDNA levels . Themag-
nitude of this effect was correlated with the time of antibody
addition ; antibody added 1-12 hafter infection inhibited viral
DNA accumulation to a greater extent than antibody added
24-48h after infection . Neutralizing mAbadded 12 or more
hours after infection had no significant effect on cell-free reverse
transcriptase activity orp24 antigen accumulation (Table 1) .
Cytopathology in HIV-1-infected CEM cell cultures was
measured by theappearance ofmultinucleated, giant cell syn-
cytia (9, 28). The frequency of syncytia was reduced sig-
nificantlywhen infected cellswere exposed to the 110.4 neu-
tralizingmAb either before or after infection (Table 2) . In
general, the decrease in syncytium frequencywas correlated
with reduced levels ofunintegrated viralDNA; however, some
syncytia were noted in the cultures that received antibody
at 1 h after infection, even though viralDNA was not de-
tected by blot hybridization of these samples .
Effects ofAZT on ViralDNA Accumulation, Virus Produc-
tion, andCytopathology . The impact of reinfection and viral
DNA accumulation was also examined by analyzing the effects
12±2 16±2 18±4 23±5
45
￿
48
￿
51
￿
116
' NA indicates that antibody was not added to this sample and -1 represents a 1-h pretreatment with antibody before virus infection.
t Virus production assessed by reverse transcriptase assay ofcell-free culture supernatants collected 3 d after infection. Units are 103cpm of [32P]TTP
incorporated in a 2-h assay (49) and are the averages of triplicate determinations from each of three independent infection experiments .
S The data are represented as nanograms of p24 per milliliter of culture supernatant . The standard error in p24 determinations did not exceed 15%
of the mean values .1038
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ofAZT on HIV-1 infection ofCEM cells . Virus production
measured by cell-free reverse transcriptase activity was exam-
ined 3d after infection as a function of the AZT concentra-
tion added before infection (Fig. 3) . Virus production was
inhibited 50% at 25 ± 16 nM AZT, 5 1 .M AZT was re-
quired to inhibit virus production by 90% (Fig. 3 A) . The
value of 25nM AZT for 50% inhibition of virus production
is in accord with inhibitory concentrations measured by p24
production (29), plaque formation (23), or cell-free reverse
transcriptase activity (30) .
Similar dose-response experiments were then performed
to evaluate AZT effects on viralDNA accumulation 3 d after
infection . The addition of 0.01 nM to 100 nM AZT before
infection inhibited HIV-1DNA accumulation (Fig . 3 B) . By
counting radioactivity in bands of DNA excised from hy-
bridization membranes, these experiments yielded quantita-
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Figure 3 .
￿
Inhibition of HIV-1 infection by 3'-azido-3`-deoxythymidine. CEM cells were treated with AZT for 1 h and then infected with HIV-1
at a multiplicity of 1 TCIDSO/cell. Viral DNA and cell-free supernatants were obtained from cultures 3 d after infection. (A) Blot hybridization of
unintegrated viral DNA accumulated in the presence of AZT, the DNA samples were digested with BamHI restriction endonuclease. The positions
of circular and linearDNA species are indicated at the left and theAZT concentration (nM) is shown at the top. (B) Quantitation of virus production
and unintegratedDNA accumulation 3 d afterinfection at varying concentrations ofAZT. ViralDNA levels (filkd symbols) were quantitatedby removing
and counting radioactive bands from the hybridization membrane; areas of the membrane containing circular and linear viralDNA were excised . The
data were normalized to a value of 1 for the no drug treatment samples. Cell-free reverse transcriptase activity was assayed (49) and is indicated by
the open symbols . The results for reverse transcriptase assays are the averages of triplicate determinations . Three independent infections were assayed
for reverse transcriptase activity and two independent infection experiments were quantitated for viral DNA accumulation .
tive information showing that viralDNA accumulation was
inhibited by50% at 60pM AZT and by90% at 10 nMAZT
(Fig. 3 A) . We also tested AZT doses as high as 100 IAM
and as low as 0.1 pM (not shown) ; the concentration range
shown here was selected to emphasize the linear portion of
the dose-response curve for inhibition of viralDNA accumu-
lation by AZT Adding AZT before infection also inhibited
cytopathology in infected cell cultures . Significant reduction
in syncytium frequency at 3 d after infection was seen with
as little as 10 nM AZT in the culture medium (Table 3) .
Effects ofNeutralizing Antibody orAZT on Viral DNA Ac-
cumulation in a Persistently Infected T Cell Line . In addition
to initiating acute, cytopathic infection ofCEM cells, HIV-1
can also establish a persistent infection in these cells (19) . The
cloned cell line HCEM, for example, contains a single in-
tegrated provirus (not shown) and is fully capable offormingTable 2.
￿
Neutralizing mAb Added after Infection Inhibits
Syncytium Formation in Infected CEM Cells
" Syncytia 3 d after infection were counted within a single field observed
using lowerpower objectives (total magnification, x 200) . Syncytia were
defined because they were multinucleated or they were larger than three
cell diameters; at least five fields were counted for each sample . Values
given in the firstrow represent the numerical averages of syncytium fre-
quency data obtained from observing four independent infection experi-
ments . The values from independent data sets were averaged, after
discarding the single value farthest from the mean .
syncytia in the presence of uninfected CD4+ cells, although
this cell line resists homotypic fusion. During logarithmic
growth, HCEM cultures produce ti5 x 105 TCID5o/ml of
infectious HIV -1 in the culture medium .
Theobservation ofunintegrated viralDNAin HCEM cells
(19) prompted investigation of the mechanisms responsible
for maintaining theseDNA species . The effects of AZT or
neutralizing mAb on unintegrated viralDNA were exam-
ined.HCEM cells were washed andrecultured in freshmedium
to reduce as much as possible the input titer of soluble virus.
Unintegrated viralDNA decreased within 1dafterAZT treat-
ment ofthesewashed cells (Fig. 4) . Therewas very little effect
of AZT on viral DNA levels at 3 d after treatment. AZT
Table 3.
￿
AZT Inhibits Syncytium Formation in Infected
CEM Cells
" Syncytia at 3 d after infection were counted within a single field ob-
served usinglow power objectives (total magnification, x 200) . Syncytia
were defined because they were multinucleated or they were larger than
three cell diameters ; at least five fields were counted for each sample . Values
shown in the first row represent the numerical averages of syncytium
frequency data obtained from four independent infection experiments .
The values from independent data sets were averaged, after discarding
the single value farthest from the mean .
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Figure 4.
￿
Time course ofinhibition of viralDNA accumulation inacutely
and persistently infected CEM cellsbyAZT .AZTwas added to cultures
1 h before the addition of virus (acute infection lanes are labeled CEM) .
Drugwas added to the mediumofpersistently infectedHCEM after washing
these cells to remove exogenous virus. The concentrations ofAZT are
indicated. Samples were collected 1 or 3 d later and viral DNA was ex-
tracted, digested, fractionated byelectrophoresis, and analyzed by blot hy-
bridization as in Fig. 1 . The positions of the three species of viral DNA
are indicated at the left.
treatment also had no effect on virus production by HCEM
cells (not shown), a result consistent with previous observa-
tionsby others (31, 32). Apparently, constitutive virusproduc-
tion combined with what may have been diminishing AZT
concentrations in the medium, permitted accumulation of
viral DNA to near normal levels within 3 d after drug
treatment .
Neutralizing mAb 110.4 was also utilized to block rein-
fection ofHCEM cells. Evaluation ofthe levels ofunintegrated
viralDNA 3 d after treatment supportedtheview that rein-
fection leads to viralDNAaccumulation in HCEM cells (Fig.
5) . ViralDNAlevels inHCEM were significantly lower than
the levels seen in cells acutely infected with HIV-1 for 3 d
(Figs. 4 and 5) .
Discussion
The accumulation of unintegrated viralDNA is a charac-
teristic of the acute, cytopathic HIV-1 infection of T cells
(19, 33, 34) . In this study, similar accumulation ofunintegrated
HIV -1 DNA was shown to occur over 3 d after infection
by a mechanismrequiring reinfection of already infected cells .
This accumulation of viralDNA correlated with theextent
of cytopathology in the cultures. HIV -1 is thus similar to
the cytopathic avian oncornaviruses which infect, replicate,
and reinfect target cells more rapidly than these cells estab-
lish interference immunity (13, 14) . Addition of neutralizing
AZT concentration (nM)
0 0.1 1 10 100 1,000
Syncytia/field
(average)" 86 91 83 32 23 11
Range of
values 73-141 77-108 78-115 21-52 13-31 4-23
Antibody addition
(h, after infection) NA -1 1 12 24 48
Syncytia/field" 78 0 12 13 17 20
Range of values 71-125 0 10-21 8-21 11-26 19-45Figure 5 .
￿
Neutralizing antibody prevents accumulation of viral DNA
in persistently infectedHCEM cells. Infection and analysis ofDNA were
as described for Fig . 4 . The acute and persistent infection lanes are indi-
cated at the top along with (-) to indicate no antibody in the culture
or (+) to show the presence ofantibody. For the acute infection, the hours
after infection for antibody addition areindicated; the cells wereharvested
at 3 d after infection. The persistently infected cells were washed and
resuspended in fresh medium containing antibody, then cultured for 3 d
and collected for analysis of DNA .
mAb or AZT to already infected cells reduced the levels of
unintegrated viralDNA without affecting the rates of virus
production . Therefore, unintegrated DNA does not contribute
significantly to the rates of virus production and does not
promote cytopathic effects by spreading the infection within
the culture . It is possible that transcription of unintegrated
DNA might generate viral gene products that promote syn-
cytium formation or are directly toxic to cells . It is also pos-
sible that unintegratedDNA itself might induce a lethal cel-
lular process. However, it remains a formal possibility that
viralDNA accumulation is only associated with developing
cytopathology and is not a direct cause of cell death .
This characterization of cytopathic HIV-1 infection may
explain some of the recognized features ofAZT activity. We
and others (31, 32) have reported that AZT treatment does
not inhibit virus production in persistently infected T cell
lines . Initially this result seemed to conflict with the obser-
vation that AZT inhibited viralDNA accumulation in these
cells . The analysis of virus production in cells treated after
infection with neutralizing mAb indicated that virus produc-
tion rates were independent of unintegrated viralDNA ac-
cumulation . Accordingly, AZT treatment failed to affect HIV-1
production by persistently infected HCEM cells .
Smith et al . reported thatT cell cultures infected and main-
tained in the presence of 25 j.M AZT showed rates of HIV-1
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replication 20 d after infection identical to infected cultures
not treated with AZT (35) . Apparently, the initial infection
was efficiently though incompletely inhibited byAZT Con-
tinued presence of the drug reduced reinfection of the small
fraction of already infected cells and prevented the develop-
ment of cytopathology. The infected cells were thus able to
survive and to produce virus that slowly spread throughout
the culture. Within 20 d after infection this slow process ap-
parently had proceeded to the point where virus production
in the treated cultures equalled the rates ofvirus production
in cultures .infected in the absence . of AZT.
In addition to its demonstrated value as an antiviral agent
for the treatment ofHIV-1 infection (36, 37), AZT also has
the potential to modulate cytopathic HIV-1 infection ofT
cells to a form'that is persistent and noncytopathic. This fea-
ture of drug action is due to inhibiting reinfection of already
infected cells and requires lower concentrations of drug than
are necessary to inhibit primary infection . This difference is
probably attributable to the fact that accumulation of unin-
tegrated viralDNA and cytopathology result from multiple,
cumulative reinfections only a proportion of which must be
inhibited to modulate the infection . In the presence ofAZT,
infected cells survive and continue to produce virus because
they are not destroyed by viral cytopathic effects . However,
removal of AZT from cultures infected in the presence of
the drug resulted in rapid development ofcytopathology (not
shown) . Therefore, AZT treatment modulates the effects of
HIV-1 infection and generates a type of persistent infection
that is transient and depends on continuedpresence of the drug.
The explanation for viral persistence inHCEM cells also
involves limitations on the rate of reinfection, even though
thisphenomenon is independent ofexogenous antiviral agents.
The steady-state levels of viralDNA in HCEM are reduced
considerably compared with the levels found in acutely in-
fected cells at day 3 . This finding is similar to the situation
for cells chronically infected by avian retroviruses (13, 14) and
reflects an important cellular adaptation to infection that facili-
tates establishment of virus persistence. HIV-1-infected cells
areknown to have decreased numbers of surfaceCD4 receptors
(38-41) and similar observations have been made forHCEM
cells (not shown) . Reduced receptor levels appear to be a key
alteration in this cell line that decreases reinfection rates . There-
fore, antiviral agents or decreased receptor levels can limit
reinfection of already infected cells and promote the estab-
lishment and maintenance of persistent HIV-1 infection of
T cells . Importantly, these mechanisms operate on virulent
HIV-1 strains and do not require selection of mutationally
altered viruses (42) in order to establish a persistent infection .
This model for the role of reinfection and unintegrated
viral DNA in HIV-1 cytopathology may not apply to the
situation of monocytes and macrophages. The unintegrated
viral DNA present in persistently infected monocytic cells
is structurally distinct from the viralDNA forms discussed
here and appears to replicate autonomously (19) .
It is unclear how the in vitro observations resulting from
these studies apply to T cell destruction in vivo. The inter-
play of infectious, circulating free virus (43, 44), neutralizing
antibody, and cellular heterogeneity in different tissues makethe in vivo relationships difficult to characterize. Neverthe-
less, initial efforts to document the accumulation of unin-
tegrated retroviralDNA and to correlate this with pathology
(15, 16, 45) suggest that the processes described in our studies
may apply to the situation in vivo. Moreover, recent observa-
References
We are grateful to Drs. Howard Temin, Mel Cohn, Maria Salvato, and Mandal Singh for critical reviews
of the manuscript .
This work wassupported by grant AI-24591 from the National Institute ofAllergyand Infectious Disease
(C.D. Pauza) ; by National Institutes of Health grants AI-62548, AI-52578, HB-67019 ; and by the Vet-
erans Administration (D.D. Richman) .
Address correspondence toDr. C. David Pauza, Department ofPathologyandLaboratory Medicine, Univer-
sity ofWisconsin-Madison Medical School, 505 Services Memorial Institute, 1300 University Ave., Madison,
WI 53706 .
Received for publication 1 June 1990.
1041
￿
Nuza et al.
tions of beneficial effects of lower AZT doses (46-48) may
relate to our observations of the effects of AZT on cyto-
pathology at concentrations significantly lower than those
required to inhibit primary infection .
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